Li Auto Inc. Shareholder Investigation: Submit Your Losses to Johnson Fistel
January 07, 2023 10:46 ET
|
Johnson Fistel, LLP
SAN DIEGO, Jan. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Li Auto Inc. (NASDAQ: LI), any of its executive officers, or others violated...
Amarillo receives regulatory approval for Posse power line
October 25, 2021 09:07 ET
|
Amarillo Gold Corp.
TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Construction can begin on a power line that will deliver electricity to the Posse Gold Mine, said Amarillo Gold Corporation (TSXV: AGC, OTCQB: AGCBF)...
Amarillo receives License to Install for Posse
February 04, 2021 09:40 ET
|
Amarillo Gold Corp.
TORONTO, Feb. 04, 2021 (GLOBE NEWSWIRE) -- State regulators have approved the Posse Gold Mine, said Amarillo Gold Corporation today after receiving the License to Install (LI) for its project on the...
American Lithium Comments on Recent Promotional Activity
January 15, 2021 19:18 ET
|
American Lithium Corp.
VANCOUVER, British Columbia, Jan. 15, 2021 (GLOBE NEWSWIRE) -- American Lithium Corp. (TSXV: LI) (OTCQB: LIACF) (Frankfurt: 5LA1) (“American Lithium” or the “Company”) has been requested by OTC...
New Point Acquires Empire Lithium Property in Nevada
May 22, 2018 03:05 ET
|
New Point Exploration Corp.
VANCOUVER, British Columbia, May 22, 2018 (GLOBE NEWSWIRE) -- New Point Exploration Corp. (CSE:NP) (Frankfurt:4NP) (“New Point” or the “Company”) is pleased to announce that it has entered into a...
Alabama Graphite Provides Corporate Update
October 16, 2017 14:54 ET
|
Alabama Graphite Corp.
The Energy Graphite™ Company Sourced and Manufactured in the United States of America TORONTO, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Alabama Graphite Corp. (“Alabama Graphite” or the “Company”)...
CeNeS Announces Licensing Deal with Acorda for its Multiple Sclerosis Drug Candidate
November 13, 2002 04:04 ET
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Nov. 13, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it had signed an agreement to out-licence its recombinant glial growth factor...